Fibrocell Science Inc (FCSC) 2007年年度报告「NASDAQ」.pdf

《Fibrocell Science Inc (FCSC) 2007年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Fibrocell Science Inc (FCSC) 2007年年度报告「NASDAQ」.pdf（141页珍藏版）》请在三个皮匠报告上搜索。

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the fiscal year ended December 31,2007OR o Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange

2、 Act of 1934 Isolagen,Inc.(Exact name of registrant as specified in its Charter.)Delaware(State or other jurisdiction of incorporation)001-31564(Commission File Number)87-0458888(I.R.S.EmployerIdentification No.)405 Eagleview BoulevardExton,Pennsylvania 19341(Address of principal executive offices,i

3、ncluding zip code)(484)713-6000(Issuers telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of Each Class Name of Each Exchange on which RegisteredCommon Stock,$.001 par value American Stock Exchange Indicate by check mark if the registrant is a well-

4、known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes o No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes o No Indicate by check mark whether the registrant:(1)filed all reports required to be filed by S

5、ection 13 or 15(d)of theExchange Act during the preceding 12 months(or for any shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No oIndicate by check mark if there is no disclosure of delinquent filers i

6、n response to Item 405 of Regulation S-K contained inthis form,and no disclosure will be contained,to the best of registrants knowledge,in definitive proxy or informationstatements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.oIndicate by check mark whet